INDIA – India’s healthcare solutions provider GenWorks has launched its high-tech mechanical system for conducting a hysteroscopic tissue removal procedure.
GenWorks, originally a Wipro GE-invested company, has a diverse portfolio in chemistry, haematology, urinalysis, immunoassay, and point-of-care tests.
The new mechanical hysteroscopic tissue removal system is GenWorks’ effective way to bring in surgical approaches that are quick, and minimally invasive.
The average procedure time for polyps and fibroids removal is relatively lesser when done with a mechanical hysteroscopic tissue removal system.
In a press release, the company said: “Our mechanical hysteroscopic tissue removal system is made to provide direct visualization of the intrauterine cavity and has efficient tissue removal capabilities.”
Moreover, GenWorks’ minimally invasive system has been used in more than 1,40,000 procedures until now.
It has been found to completely remove endometrial fibroids and polyps thus preventing the formation of cancerous cells.
Hysteroscopic tissue removal systems have shown a major advantage in the successful removal of the pathology and total operation time.
GenWorks’ newly launched system uses a simple mechanical approach for removing intrauterine tissues in comparison to traditional hysteroscopy techniques like resectoscopy.
The system has a built-in clear operative field with a continuous hysteroscopic outflow that allows doctors to utilize the benefits of the exclusive feature including no tissue floats within the uterine cavity.
Commenting on the importance of minimally invasive procedures, GenWorks noted: “The new system offers a safe and gentle resection which is designed to eliminate the risk of energy discharge and the proprietary suction control minimizes fluid use.”
GenWorks’ mechanical hysteroscopic tissue removal system will provide surgeons with a precision tool that can be used to increase access to minimally invasive surgical procedures and improve health outcomes.
This highly effective solution is part of the company’s strategic objectives to make healthcare solutions affordable, accessible, and equitable in India.
The mechanical hysteroscopic tissue removal procedure is done by inserting the hysteroscope into the uterus, dissenting the uterus with the saline, and locating the intrauterine abnormality.
After successful locating of the pathology, the shaver is placed against the pathology in the lining of the uterus, simultaneously aspirating, and cutting tissue.
The final step of the hysteroscopy procedure is removing the shaver and the hysteroscope from the uterus and the polyp or fibroid can then be retrieved by the surgeon.
The process is efficient because it involves a single insertion and a few procedural steps. Moreover, it helps in targeted removal under continuous visualization.
What sets apart GenWorks’ mechanical hysteroscopic tissue removal system is its ability to capture all the tissue needed for pathological analysis.
“The soft tissue shavers respect pathology down to its base and allow tissue capture for histological confirmation through simultaneous cutting and aspiration,” stated GenWorks.
The company has been consistently working to empower healthcare professionals operating in rural areas to deliver better medical facilities and diagnostics at an affordable price.
The healthcare solutions provider also launched its new breath analyzer product, FenomPr, which works as a simple tool for the diagnosis, screening, and monitoring of Asthma patients.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
